Cafepharma Today

February 14 2025 - Moderna beats on revenue but loses more than expected as it scales down manufacturing
Moderna beats on revenue but loses more than expected as it scales down manufacturing
Pending US vaccine decisions as Kennedy takes top health job
Bristol Myers Squibb comes up short in bid to expand Opdualag in melanoma
Corbus posts first US data on challenger to Pfizer’s ADC Padcev
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
CNW Telbec, Canada
Saturday, August 23, 2008 - 10:39am
tags:
FDA wants clear drug labels
Allentown Morning Call, PA
Saturday, August 23, 2008 - 10:37am
tags:
Owning Abbott shares a 'badge of honor'
Waukegan News Sun, IL
Saturday, August 23, 2008 - 10:35am
tags:
Cymbalta Receives European Approval For The Treatment Of Generalised Anxiety Disorder
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
Indevus Pharmaceuticals Announces Completion Of Enrollment In Phase III Trial Of PRO 2000
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
FDA Needs Nine More Months to Study Vytorin, Cancer Link
MedHeadlines
Saturday, August 23, 2008 - 10:30am
tags:
Health Winners & Losers: Alpharma
Yahoo/TheStreet.com
Friday, August 22, 2008 - 7:23pm
tags:
BioMarin Pharmaceutical shares rise on long-term outlook for genetic disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 7:22pm
tags:
FDA rule on drug labeling attracts praise from drugmakers, ire from lawyers
Yahoo/AP
Friday, August 22, 2008 - 7:21pm
tags:
Pharma Deals: Start Hostile. Get Friendly.
WSJ Online
Friday, August 22, 2008 - 7:20pm
tags:
King Pharma raises pressure on rival
Financial Times
Friday, August 22, 2008 - 7:19pm
tags:
Abbott Tries a Crash Diet
Motley Fool
Friday, August 22, 2008 - 4:27pm
tags:
Amgen's Nplate Approved by U.S. for Bleeding Disorder
Bloomberg
Friday, August 22, 2008 - 3:18pm
tags:
Alpharma shares surge on King buyout offer
Forbes
Friday, August 22, 2008 - 3:17pm
tags:
Genentech Ditches Stock Options to Fund $371 Million Retention Plan
WSJ Online
Friday, August 22, 2008 - 10:02am
tags:
Merger Watch: APP Pharmaceuticals - Fresenius
Seeking Alpha
Friday, August 22, 2008 - 10:01am
tags:
Onyx and Bayer say patients are enrolling in trial of Nexavar for liver cancer
Yahoo/AP
Friday, August 22, 2008 - 9:39am
tags:
Eli Lilly's Cymbalta gets expanded European approval as anxiety disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 9:36am
tags:
Fresenius Stays Strong in Tough Times
Businessweek
Friday, August 22, 2008 - 9:34am
tags:
FDA: Vytorin Not Linked to Cancer Risk
WSJ Online
Friday, August 22, 2008 - 9:33am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Compliance is Futile Without Transparency: 340B, MDRP, MFP Overlap Lead to Iceberg Ahead
Drug Channels
AI Antibodies? Really?
In the Pipeline
Stand Up And Be Counted
In the Pipeline
Why Plan Sponsors and PBMs Are Still Falling Hard for Copay Maximizers
Drug Channels
Huntington's Disease, Cell by Cell
In the Pipeline
The Continuing NIH/NSF Crisis, Part III: Indirect Costs
In the Pipeline
Vaccines Through Protein Degradation
In the Pipeline
Today’s Rare Disease Launches Require the Right Specialty Pharmacy Partner
Drug Channels
An Evaluation of "Deep Research" Performance
In the Pipeline

Latest Jobs

Cell Therapy Navigator
Houston, Texas, 77002
Inizio Engage
Rapid Deployment Representative
Fort Worth, Texas, 76102
Inizio Engage
Rapid Deployment Representative
Charlotte, North Carolina, 28245
Inizio Engage
Oncology Key Account Manager
Newark, New Jersey, 07175
Inizio Engage
Cell Therapy Navigator
Little Rock, Arkansas, 72208
Inizio Engage
Territory Business Manager
Philadelphia, Pennsylvania, 19107
Inizio Engage
Business Development Representative
Las Vegas, Nevada, 89105
Professional Case Management
Oncology Key Account Manager
Atlanta, Georgia, 30383
Inizio Engage
Territory Manager, Surgical Pain - South Houston, TX
TX,
Avanos Medical
Neurology Account Manager- MD/DC/N VA (Remote)
Annapolis, Maryland, 21401
Jazz Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information